Skip to main content
Erschienen in: Reactions Weekly 1/2024

01.03.2024 | Case report

Ceftriaxone/Flucloxacillin

Lack of efficacy

Erschienen in: Reactions Weekly | Ausgabe 1/2024

Einloggen, um Zugang zu erhalten

Excerpt

Author Information
An event is serious (based on the ICH definition) when the patient outcome is:
  • * death
  • * life-threatening
  • * hospitalisation
  • * disability
  • * congenital anomaly
  • * other medically important event
Literatur
Zurück zum Zitat Tavares APGG. NATIVE MITRAL VALVE MSSA ENDOCARDITIS. European Journal of Case Reports in Internal Medicine 8 (Suppl. 1): 222 abstr. PV543, Jan 2021. Available from: URL: https://dx.doi.org/10.12890/2021_V8Sup1 [abstract] Tavares APGG. NATIVE MITRAL VALVE MSSA ENDOCARDITIS. European Journal of Case Reports in Internal Medicine 8 (Suppl. 1): 222 abstr. PV543, Jan 2021. Available from: URL: https://dx.doi.org/10.12890/2021_V8Sup1 [abstract]
Metadaten
Titel
Ceftriaxone/Flucloxacillin
Lack of efficacy
Publikationsdatum
01.03.2024
Verlag
Springer International Publishing
Erschienen in
Reactions Weekly / Ausgabe 1/2024
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI
https://doi.org/10.1007/s40278-024-54428-4

Weitere Artikel der Ausgabe 1/2024

Reactions Weekly 1/2024 Zur Ausgabe

Case report

Cefepime

Case report

Multiple drugs